Summary & Overview
HCPCS J1650: Enoxaparin Sodium Injection, 10 mg
HCPCS Level II code J1650 denotes a 10 mg injection of enoxaparin sodium, a commonly used low-molecular-weight heparin for thromboprophylaxis and anticoagulation management. As an injectable drug code billed across outpatient and inpatient settings, J1650 is relevant to hospital systems, physician practices, ambulatory infusion centers, and payers because of its clinical role and frequent use in surgical, medical, and emergency care.
This analysis covers national payer perspectives including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of typical coverage patterns, reimbursement benchmarks, and billing considerations tied to medication unitization and site-of-service differences. The publication also summarizes clinical context for enoxaparin use, common billing scenarios for short-duration prophylaxis dosing, and points of administrative attention such as correct HCPCS identification and service-line classification.
The report does not make clinical recommendations but provides operationally relevant information for billing, coding, and revenue cycle teams: what the code represents, where it is commonly billed, how major payers approach coverage, and which benchmarks and policy updates to watch for when managing injectable anticoagulant claims nationally.
Billing Code Overview
HCPCS Level II code J1650 represents an injection of enoxaparin sodium, 10 mg. The service is a pharmacologic anticoagulant administration delivered as a billed drug unit. Typical site of service for this injectable medication includes outpatient clinics, physician offices, infusion centers, emergency departments, and inpatient hospital settings where low-molecular-weight heparin is administered for prophylaxis or treatment of thromboembolic conditions.
Service type: Medication administration / injectable anticoagulant
Typical site of service: Outpatient clinic, physician office, infusion center, emergency department, inpatient hospital
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 68-year-old female patient with a history of atrial fibrillation and recent knee replacement presents to the outpatient surgical clinic for postoperative anticoagulant prophylaxis. The clinician prescribes subcutaneous enoxaparin sodium 10 mg for venous thromboembolism prophylaxis in a patient with body habitus or renal function that requires a lower fixed dose (for example, geriatric patient on multiple interacting medications or when device-delivered dosing requires a 10 mg cartridge). The medication is prepared and administered by a licensed nurse in the clinic or by the patient/caregiver after education for home administration. Documentation includes the indication, dose (10 mg), route (subcutaneous), date and time of administration, lot number, and site of injection. Billing is performed using HCPCS Level II code J1650 for the Injection, enoxaparin sodium, 10 mg, with an appropriate modifier if required to report the service context (for example, bilateral procedure modifier for related services or patient status modifiers). Typical sites of service for this drug include outpatient clinic, ambulatory surgical center, emergency department, and patient home when delivered as a take-home syringe.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|